Interleukin Genetics
Watham, US · Delaware corporation · 1 known investors
Biotech
Founders & leadership
KK
Kenneth KornmanExecutive Officer, Director
SD
Stephen DiPalmaExecutive Officer
JL
Joseph LandstraDirector
LC
Lionel CarnotDirector
DM
Dayton MisfeldtDirector
JW
James WeaverDirector
RC
Roger ColmanDirector
WM
William Mills IIIDirector
Investors · 1
Reported raises · per SEC filings
Form D private placements▶$5.6MraisedAug 2016 · 10 investors · BiotechnologyRule 506(b)
▶$5.6MraisedAug 2016 · 10 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Joseph M. LandstraDirector
- Kenneth S. KornmanExecutive Officer, Director
- Stephen DiPalmaExecutive Officer
- James WeaverDirector
- Roger ColmanDirector
- Mark B. CarbeauExecutive Officer, Director
- Dayton MisfeldtDirector
- William C. Mills IIIDirector
- Lionel CarnotDirector
- Offering amount
- $5.6M
- Amount sold
- $5.6M
- First sale
- Jul 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$5MraisedJan 2015 · 9 investors · BiotechnologyRule 506(b)
▶$5MraisedJan 2015 · 9 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Joseph LandstraDirector
- Kenneth KornmanExecutive Officer, Director
- Lionel CarnotDirector
- Roger ColmanDirector
- Dayton MisfeldtDirector
- Stephen DiPalmaExecutive Officer
- James WeaverDirector
- William Mills IIIDirector
- Offering amount
- $5M
- Amount sold
- $5M
- Sales commissions
- $155.3K
- Placement agents
- BTIG, LLC
- First sale
- Dec 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.